The cancer drug Sutent and a dozen other medications are undergoing closer scrutiny by the Food and Drug Administration for possible risks of serious side effects, the agency said today.The FDA just released a list of drugs it is further investigating after reports of side effects were received through the agency’s Adverse Event Reporting System between January and March 2009. Appearing on the list “means that FDA has identified a potential safety issue, but does not mean that FDA has identified